PTC Therapeutics | PTCT - Sales Revenues

Ptc Therapeutics reported $217.13M in Sales Revenues for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Sales Change
Amgen AMGN:US USD 6.84B 187M
Biogen BIIB:US USD 2.54B 35.5M
Bluebird Bio BLUE:US USD 71K 1.45M
Daiichi Sankyo 4568:JP JPY 340.48B 13B
Esperion Therapeutics ESPR:US USD 18.82M 162K
Gilead Sciences GILD:US USD 7.39B 347M
Karyopharm Therapeutics KPTI:US USD 33.58M 2.56M
Novartis NOVN:VX USD 13B 159M
Pfizer PFE:US USD 24.29B 1.65B
Sangamo Biosciences SGMO:US USD 27.23M 770K
Ultragenyx Pharmaceutical RARE:US USD 103.35M 12.64M
Vertex Pharmaceuticals VRTX:US USD 2.3B 31.6M
YTE INCY:US USD 926.7M 103.4M